Author:
Birkmayer W.,Knoll J.,Riederer P.,Youdim M. B. H.,Hars Vera,Marton J.
Publisher
Springer Science and Business Media LLC
Subject
Biological Psychiatry,Psychiatry and Mental health,Clinical Neurology,Neurology
Reference40 articles.
1. Birkmayer, W., Hornykiewicz, O.: Der L-Dioxyphenylalanin-Effect beim Parkinson-Syndrom des Menschen. Arch. Psychiat. Nervenkrh.203, 560?571 (1962).
2. Birkmayer, W., Knoll, J., Riederer, P., Youdim, M. B. H.: L-Deprenyl leads to prolongation of L-dopa efficacy in Parkinson's disease. In: Monoamine Oxidase and its Selective Inhibitors (Beckmann, H., Riederer, P., eds.), pp. 170?177. Basle: Karger. 1983.
3. Birkmayer, W., Neumayer, E.: Die moderne medikamentöse Behandlung des Parkinsonismus. Z. Neurol.202, 257?280 (1972).
4. Birkmayer, W., Riederer, P., Youdim, M. B. H., Linauer, W.: Potentation of antiakinetic effect after L-dopa treatment by an inhibitor of MAO-B, l-deprenyl. J. Neural Transm.36, 303?323 (1975).
5. Burns, R. S., Chiueh, C. C., Markey, S. R., Ebert, M. H., Jacobowitz, D., Kopin, I. J.: A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by l-methyl-4-phenyl-1,2,5,6-tetrahydropyridine. Proc. Natl. Acad. Sci. U.S.A.80, 4546?4550 (1983).
Cited by
454 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献